A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401

NCT05195541 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cutia Therapeutics（Wuxi）Co.,Ltd